news
Functioning human muscle grown from induced pluripotent stem cells
First functioning human muscle grown from induced pluripotent stem cells holds promise for cellular therapies, drug discovery and studying rare diseases...
List view / Grid view
Duke University
news
gp120 protein shows promise in HIV vaccine design
Researchers have developed a vaccine candidate that spurs animals to produce antibodies against protective sugars of multiple HIV strains...
news
Cancer-causing virus masters cell’s replication & immortality
Viruses are notorious for taking over their host's operations and using them to their own advantage. But few human viruses make themselves quite as cozy as the Epstein-Barr virus, which can be found in an estimated 9/10 humans without causing any ill effects. That is, until this virus causes mononucleosis…
news
Positive results for Viking’s rare diseases in vivo study
Viking Therapeutics announced positive initial results from a proof-of-concept study of VK2809 in an in vivo model of glycogen storage disease Ia (GSD Ia).
news
Fasnall doubles survival time in mice with HER2-positive breast cancer
2 June 2016 | By Victoria White, Digital Content Producer
Fasnall appears to impede a process that fuels breast cancer in mice, a discovery that could have implications in the treatment of a host of cancers...
news
Duke scientists discover new class of pain relievers
1 June 2016 | By Victoria White, Digital Content Producer
In a study, the compound 16-8 also quelled pain in living animals, including abdominal aches in mice with pancreas inflammation...
news
Scientists prevent breast cancer cells entering bone marrow
25 May 2016 | By Victoria White, Digital Content Producer
Scientists have identified a molecular key that breast cancer cells use to invade bone marrow in mice, where they may be protected from therapies...
news
Autism model offers insights to possible drug targets
10 May 2016 | By Victoria White, Digital Content Producer
A new mouse model of a genetically-linked type of autism, developed by scientists at Duke Health, reveals more about the role of genes in the disorder...
news
Researchers freeze EBV by disrupting the cell supply chain
20 January 2016 | By Victoria White
Researchers made B-cells sense they were starving by using the drug Rapamycin, enabling them to turn the senescence of EBV-infected cells on and off...
